|
Search
Collections
Benchmarks
Upload document
Product
HEC121120
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
2 indications
Indication
Hepatitis B
Indication
Chronic
Clinical trial
A Single-center, Randomized, Double-blind, Single and Multiple Dosing, Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
Status:
, Estimated PCD: 2023-12-30